---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-031420"
form_type: "8-K"
ticker: "TBPH"
cik: "0001583107"
company_name: "Theravance Biopharma, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:27:16.832843+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Theravance Biopharma confirms zero exposure to Silicon Valley Bank

## Summary
- Company states it holds no cash deposits or securities at Silicon Valley Bank.
- Disclosure addresses potential investor concerns about SVB's March 2023 collapse.
- No financial impact or operational disruption related to SVB's failure.

## SEC filing metadata
- accession: 0001104659-23-031420
- form_type: 8-K
- ticker: TBPH
- cik: 0001583107
- company_name: Theravance Biopharma, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583107/000110465923031420/0001104659-23-031420-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583107/000110465923031420/tm239223d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-031420
- JSON: https://secwatch.observer/filing/0001104659-23-031420.json
- Plain text: https://secwatch.observer/filing/0001104659-23-031420.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.